Article
Potentiation of antibacterial activity of the MB-1 siderophore-monobactam conjugate using an efflux pump inhibitor.
Antimicrobial agents and chemotherapy - 1 Apr 2015
Tomaras Andrew P, Crandon Jared L, McPherson Craig J, Nicolau David P
Abstract excerpt
Preliminary enthusiasm over the encouraging spectrum and in vitro activities of siderophore conjugates, such as MB-1, was recently tempered by unexpected variability in in vivo efficacy. The need for these conjugates to compete for iron with endogenously produced siderophores has exposed a significant liability for this novel antibacterial strategy. Here, we have exploited dependence on efflux for siderophore...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
